160 related articles for article (PubMed ID: 36742247)
1. Trends in the Epidemiology of Brucellosis Cases in Iran during the Last Decade.
Zeinali M; Doosti S; Amiri B; Gouya MM; Godwin GN
Iran J Public Health; 2022 Dec; 51(12):2791-2798. PubMed ID: 36742247
[TBL] [Abstract][Full Text] [Related]
2. Trends of human brucellosis in Central Iran (2010-2018).
Khalilian MS; Ramazanpour J; Hosseini SM; Narrei S; Zeinalian M
J Res Med Sci; 2021; 26():55. PubMed ID: 34729063
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological, laboratory, diagnostic and public health aspects of human brucellosis in western Iran.
Kassiri H; Amani H; Lotfi M
Asian Pac J Trop Biomed; 2013 Aug; 3(8):589-94; discussion 593-4. PubMed ID: 23905014
[TBL] [Abstract][Full Text] [Related]
4. Epidemiologic, clinical, and laboratory characteristics of childhood brucellosis : A study in an Iranian children's referral hospital.
Pourakbari B; Abdolsalehi M; Mahmoudi S; Banar M; Masoumpour F; Mamishi S
Wien Med Wochenschr; 2019 Jun; 169(9-10):232-239. PubMed ID: 30778882
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Risk Factors of Brucellosis in Kermanshah Province, Iran During 2010-2014.
Rajabi J; Hamidi-Farahani R; Mansouri F; Soleiman-Meigooni S
Infect Disord Drug Targets; 2020; 20(2):203-207. PubMed ID: 30539704
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of Brucellosis among high risk individuals in Guilan, Iran.
Nikokar I; Hosseinpour M; Asmar M; Pirmohbatei S; Hakeimei F; Razavei MT
J Res Med Sci; 2011 Oct; 16(10):1366-71. PubMed ID: 22973333
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of human brucellosis in Nahavand county, Hamadan Province, western Iran: an 8-year (2010-2017) registry-based analysis.
Khazaei S; Solgi M; Goodarzi S; Khazaei L; Salehi I; Jenabi E
Asian Biomed (Res Rev News); 2020 Aug; 14(4):151-158. PubMed ID: 37551387
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological characteristics of human brucellosis in Hamadan Province during 2009-2015: results from the National Notifiable Diseases Surveillance System.
Nematollahi S; Ayubi E; Karami M; Khazaei S; Shojaeian M; Zamani R; Mansori K; Gholamaliee B
Int J Infect Dis; 2017 Aug; 61():56-61. PubMed ID: 28602765
[TBL] [Abstract][Full Text] [Related]
9. Human Brucellosis in Greece, 2005-2020: A Persistent Public Health Problem.
Kefaloudi C; Mellou K; Dougas G; Vorou R; Mitrou K; Kontopidou F
Vector Borne Zoonotic Dis; 2022 Mar; 22(3):163-169. PubMed ID: 35319918
[TBL] [Abstract][Full Text] [Related]
10. Changing Patterns in Epidemiology of Brucellosis in the South of Iran (2015-2020): Based on Cochrane-Armitage Trend Test.
Delam H; Keshtkaran Z; Rezaei B; Soufi O; Bazrafshan MR
Ann Glob Health; 2022; 88(1):11. PubMed ID: 35223430
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of human brucellosis in Isfahan, Iran.
Sabbaghian H; Nadim A
J Hyg (Lond); 1974 Oct; 73(2):221-8. PubMed ID: 4529097
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological, Risk Factors, Clinical, and Laboratory Features of Brucellosis in the Southwest of Iran within 2009-2015.
Nabavi M; Hatami H; Jamaliarand H
Int J Prev Med; 2019; 10():108. PubMed ID: 31360355
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological features of human brucellosis in central Iran, 2006-2011.
Zeinalian Dastjerdi M; Fadaei Nobari R; Ramazanpour J
Public Health; 2012 Dec; 126(12):1058-62. PubMed ID: 22884862
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for human brucellosis in Iran: a case-control study.
Sofian M; Aghakhani A; Velayati AA; Banifazl M; Eslamifar A; Ramezani A
Int J Infect Dis; 2008 Mar; 12(2):157-61. PubMed ID: 17698385
[TBL] [Abstract][Full Text] [Related]
15. Human brucellosis: sero-prevalence and associated risk factors in agro-pastoral communities of Kiboga District, Central Uganda.
Tumwine G; Matovu E; Kabasa JD; Owiny DO; Majalija S
BMC Public Health; 2015 Sep; 15():900. PubMed ID: 26374402
[TBL] [Abstract][Full Text] [Related]
16. The Prevalence of Brucellosis in Different Provinces of Iran during 2013-2015.
Chalabiani S; Khodadad Nazari M; Razavi Davoodi N; Shabani M; Mardani M; Sarafnejad A; Akbar Amirzargar A
Iran J Public Health; 2019 Jan; 48(1):132-138. PubMed ID: 30847321
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological Characteristics and Trend in the Incidence of Human Brucellosis in Iran from 2009 to 2017.
Norouzinezhad F; Erfani H; Norouzinejad A; Ghaffari F; Kaveh F
J Res Health Sci; 2021 Dec; 21(4):e00535. PubMed ID: 36511231
[TBL] [Abstract][Full Text] [Related]
18. A study of knowledge, attitudes and practices relating to brucellosis among small-scale dairy farmers in an urban and peri-urban area of Tajikistan.
Lindahl E; Sattorov N; Boqvist S; Magnusson U
PLoS One; 2015; 10(2):e0117318. PubMed ID: 25668783
[TBL] [Abstract][Full Text] [Related]
19. Low Prevalence of Brucella agglutinins in Blood Donors in Central Province of Iran.
Sofian M; Sheikholeslami M; Mahdaviani FA; Aghakhani A; Banifazl M; Eslamifar A; Sarmadian H; Deiri G; Ramezani A
Iran J Microbiol; 2013 Mar; 5(1):24-7. PubMed ID: 23466665
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
